Pacific Capital Partners’s BioLife Solutions BLFS Stock Holding History

Pacific Capital Partners’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-72,500	Closed	-$1.82M	–	53
2024 Q3	$1.82M	Sell	72,500 -102,500	-59%	-$2.42M	1.06%	26
2024 Q2	$3.75M	Hold	175,000	–	–	2.48%	13
2024 Q1	$3.25M	Sell	175,000 -25,000	-13%	-$437K	2.12%	17
2023 Q4	$3.25M	Sell	200,000 -75,000	-27%	-$957K	2.45%	15
2023 Q3	$3.8M	Buy	+275,000	New	+$4.33M	2.3%	15

Other funds holding BLFS

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

CRM

Cramer Rosenthal McGlynn Stamford, Connecticut $1.98B AUM 60.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Pacific Capital Partners's BLFS Position: Q4 2024 in Review

Pacific Capital Partners sold out of BioLife Solutions (BLFS) in Q4 2024, closing a stake of 72,500 shares — an estimated $1.82M sold.

Pacific Capital Partners first reported a position in BLFS in Q3 2023 and held it in 5 quarters. The position peaked at $3.8M in Q3 2023. 180 funds tracked by Wall St. Rank hold BLFS as of Q4 2024.

Pacific Capital Partners reported no remaining BioLife Solutions position as of Q4 2024 after selling out during the quarter.
Pacific Capital Partners sold 72,500 BioLife Solutions shares in Q4 2024, an estimated $1.82M.
Pacific Capital Partners first reported a position in BioLife Solutions in Q3 2023 and held it in 5 quarters.
Pacific Capital Partners's BioLife Solutions position peaked at $3.8M in Q3 2023.
180 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2024.

Based on Pacific Capital Partners's 13F filing for Q4 2024, filed 8 May 2025.